Clinical Trial Update: European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice. [NA]

View source ↗

Summary

A completed European open-label, prospective, multicenter study in adults with type 1 or type 2 diabetes previously treated with MDI or CSII, with home settings…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Type 2 Diabetes, Type 1 Diabetes | NA | Status: COMPLETED